nialamide has been researched along with Cardiomyopathies in 1 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chekunova, MP | 1 |
Suvorov, IM | 1 |
Zenkevich, ES | 1 |
Chekodanova, NV | 1 |
Minkina, NA | 1 |
1 other study available for nialamide and Cardiomyopathies
Article | Year |
---|---|
[Pathogenetic therapy of cobalt-induced cardiomyopathies].
Topics: Adrenergic beta-Antagonists; Anabolic Agents; Animals; Cardiomyopathies; Cobalt; Drug Evaluation, Pr | 1980 |